ClinicalTrials.gg
RecruitingNCT07914920Updated Nov 10, 2026

Postprandial Hypotension, Frailty and Post-Induction Hypotension in Older Patients Undergoing Noncardiac Surgery

An observational study in Post-induction Hypotension (PIH), Postprandial Hypotension and Frailty, sponsored by Konya City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Konya City Hospital · Observational

Updated Nov 10, 2026Now RecruitingSite recruiting status changed+4 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
65 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn whether a drop in blood pressure after a meal (postprandial hypotension) and frailty are linked to low blood pressure after the start of general anesthesia (post-induction hypotension) in adults aged 65 years and older having planned non-heart surgery.

The main questions it aims to answer are:

  • Do patients whose blood pressure drops after a meal have low blood pressure in the first 20 minutes after the start of anesthesia, or until surgery begins, more often than patients whose blood pressure does not drop?
  • Is frailty related to blood pressure drops after a meal and after the start of anesthesia?
  • Is the size of the blood pressure drop after a meal related to the size of the blood pressure drop and the need for blood pressure-raising medicines after the start of anesthesia?

Researchers will compare patients with and without postprandial hypotension to see if post-induction hypotension is more common in patients with postprandial hypotension. Researchers will also look at whether patients need intensive care unit admission after surgery and how long they stay in the intensive care unit and in the hospital.

Participants will:

  • Have their blood pressure and heart rate measured with an automatic arm cuff before and up to 2 hours after their usual hospital evening meal on the day before surgery
  • Answer short questions and complete simple tests for frailty (Edmonton Frail Scale) on the day before surgery
  • Answer six short questions about anxiety (Amsterdam Preoperative Anxiety and Information Scale) on the morning of surgery
  • Receive their usual anesthesia care; blood pressure values recorded during routine monitoring in the first 20 minutes after the start of anesthesia, or until surgery begins, will be collected for the study
  • Have information about intensive care unit admission and length of hospital stay collected from their medical records until discharge
Read the detailed description

Background and rationale:

Post-induction hypotension, occurring within the first 20 minutes after induction of general anesthesia or until surgical incision, is one of the most frequent periods of intraoperative hypotension and is common in older patients undergoing noncardiac surgery. Its severity and duration are associated with myocardial injury, acute kidney injury and other adverse postoperative outcomes, making preoperative identification of high-risk older patients clinically important. Age-related cardiovascular and autonomic changes, including reduced baroreflex sensitivity and diminished beta-adrenergic responsiveness, limit the ability to compensate for the sympatholytic and vasodilatory effects of anesthetic agents.

Postprandial hypotension is a frequent but under-recognized hemodynamic disorder in older adults, with a pooled prevalence of 40.5% in a recent meta-analysis, and is associated with syncope, falls, cardiovascular events and mortality. It reflects inadequate compensation for splanchnic blood pooling after a meal. Because maintaining blood pressure both after a meal and after anesthesia induction depends on adequate autonomic and cardiovascular reserve, the preoperative postprandial blood pressure response may serve as a simple, non-invasive marker of the capacity to tolerate the hemodynamic stress of anesthesia induction. Frailty, a syndrome of reduced physiological reserve across multiple systems, has been independently associated with post-induction hypotension in older surgical patients (odds ratio 2.73).

The relationship between postprandial and post-induction hypotension has been proposed in a recently published prospective cohort protocol, but clinical data remain limited. This study aims to evaluate the association between preoperative postprandial hypotension and post-induction hypotension in patients aged 65 years and older undergoing elective noncardiac surgery, to examine the relationship of frailty with both conditions, and to assess whether postprandial hypotension and frailty are independently associated with post-induction hypotension.

Data collection:

Demographic and clinical data will be recorded for all patients using standardized data collection forms, including age, sex, height, weight, body mass index, smoking status, hemoglobin level and routine preoperative biochemical laboratory values, ASA physical status, comorbidities (summarized using the Charlson Comorbidity Index) and regular medications. Antihypertensive treatments will be classified as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, calcium channel blockers, diuretics and other antihypertensive drugs, and the time of the last dose will be recorded. All medications will be continued according to routine practice and will not be changed for the study. Preoperative fasting duration, partial bowel preparation, baseline hemodynamic values, Edmonton Frail Scale and APAIS scores, type of surgery, anesthetic induction drugs and doses, perioperative fluid and vasopressor requirements, postoperative intensive care unit admission, and intensive care unit and total hospital length of stay will also be recorded.

Preoperative assessments:

On the evening before surgery, the standard hospital evening menu served at the routine dinner time will be used as the test meal for the assessment of postprandial hypotension. According to the hospital nutrition unit, the energy content of the standard evening menus is similar across days; no additional meal will be provided and meal content or timing will not be altered for the study. Meal start and end times and the proportion of the meal consumed will be recorded.

Systolic, diastolic and mean arterial pressure and heart rate will be measured in the sitting position on the upper arm with an appropriately sized cuff before the evening meal and at 30, 60, 90 and 120 minutes after meal completion. Measurements will be performed with the automated device routinely used for vital sign monitoring on the ward, using the standard vital sign measurement method; only the timing and frequency of measurements are study-specific. Whether antihypertensive medications are taken on the evening of the measurements, their timing, and whether they coincide with the meal or the postprandial measurement period will be recorded; usual medication timing will not be changed for the study. Postprandial hypotension will be defined as a decrease in systolic blood pressure of ≥20 mmHg from the pre-meal value, or a fall to ≤90 mmHg when the pre-meal value is ≥100 mmHg, within 120 minutes after the meal. To ensure an adequate meal load, only patients who consume at least 70% of the meal will be included in the primary postprandial hypotension analysis; patients who consume less will complete all measurements, but their data will not be included in the primary analysis.

During the preoperative period, frailty will be assessed with the validated Turkish version of the Edmonton Frail Scale (11 items covering 9 domains; total score 0-17). On the day of surgery, in the preoperative holding area and before any premedication, preoperative anxiety will be assessed with the validated Turkish version of the Amsterdam Preoperative Anxiety and Information Scale (APAIS; total anxiety score 4-20).

Intraoperative data collection:

Standard ASA monitoring, including electrocardiography, non-invasive arterial blood pressure, peripheral oxygen saturation and end-tidal carbon dioxide, will be applied in the operating room. With an appropriately sized cuff placed on the upper arm, after at least 3 minutes of rest in the supine position and before any sedative, opioid or anesthetic agent is administered, systolic, diastolic and mean arterial pressure, heart rate and peripheral oxygen saturation will be measured twice at 2-minute intervals, and the mean of the two measurements will be recorded as the baseline value. The baseline mean arterial pressure will be used as the reference value for defining post-induction hypotension. The amount of intravenous fluid given before induction and the time of the last antihypertensive dose will be recorded.

From the start of anesthesia induction until 20 minutes after induction or surgical incision, whichever occurs first, systolic, diastolic and mean arterial pressure and heart rate will be recorded at 2-minute intervals. Balanced crystalloid infusion will be administered before induction and throughout the study period according to routine clinical practice. Induction and maintenance agents, intravenous fluids and vasopressor/inotrope treatment will be chosen by the attending anesthesiologist according to routine practice; they will not be standardized by the investigators, and treatment of hypotension will not be delayed or modified for the study. The anesthetic and analgesic agents, neuromuscular blocking agents and premedication used, together with their doses and times of administration, will be recorded. If post-induction hypotension develops, the type, dose and timing of vasopressor or inotropic agents, fluid administration, changes in anesthetic or analgesic doses, position changes and other hemodynamic interventions will be recorded in detail.Recovery from post-induction hypotension will be defined as the return of mean arterial pressure to ≥65 mmHg and to >70% of the pre-induction baseline value.

As far as possible, the anesthesia team will be blinded to the patients' postprandial hypotension status and frailty scores to reduce performance bias. However, any clinically significant preoperative finding requiring intervention will be communicated to the clinical team to ensure patient safety.

Statistical analysis:

A total of 200 patients will be enrolled, allowing for possible data loss, to provide adequate power for the primary analysis and a sufficient number of events for the prespecified multivariable model.

Continuous variables will be presented as mean ± standard deviation or median (interquartile range) according to their distribution, and categorical variables as numbers and percentages. Between-group comparisons will be performed using the independent samples t-test or Mann-Whitney U test for continuous variables and the Pearson chi-square or Fisher exact test for categorical variables. Correlations will be assessed using Pearson or Spearman correlation analysis, according to the data distribution. A two-sided p value \<0.05 will be considered statistically significant.

Primary analysis: The incidence of post-induction hypotension will be compared between patients with and without postprandial hypotension and reported as an odds ratio with 95% confidence interval. Multivariable logistic regression will be used to assess the independent association between postprandial hypotension and post-induction hypotension, adjusted for Edmonton Frail Scale score, age, history of hypertension and chronic beta-blocker use.

Sensitivity analyses: The APAIS total anxiety score will be added to the primary model as a continuous variable, and the primary analysis will be repeated after excluding patients receiving beta-blockers.

Secondary analyses:

  • Frailty: Edmonton Frail Scale scores will be compared between patients with and without postprandial hypotension and with and without post-induction hypotension; the association of frailty with post-induction hypotension will be assessed using logistic regression.
  • Magnitude of blood pressure decreases: The Edmonton Frail Scale score will be correlated with the maximum postprandial decrease in systolic blood pressure, the lowest mean arterial pressure and the maximum decrease in mean arterial pressure after induction. The maximum postprandial decrease in systolic blood pressure will also be correlated with the lowest mean arterial pressure and the maximum decrease in mean arterial pressure after induction, and its association with post-induction hypotension will be assessed using logistic regression.
02

Conditions studied

  • Post-induction Hypotension (PIH)
  • Postprandial Hypotension
  • Frailty

Browse trials for

Keywords

  • post-induction hypotension
  • Postprandial Hypotension
  • Frailty
  • geriatric anesthesia
  • noncardiac surgery
  • Edmonton Frail Scale
03

In context

Frailty

1,284 studies on the registry are indexed under Frailty; 452 are open to participants now.

This study's planned enrollment of 200 is below the median of 225 across 493 observational studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

Konya City Hospital is the lead sponsor of 81 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 65 years and older scheduled for elective noncardiac surgery under general anesthesia at Konya City Hospital, Konya, Türkiye, who are hospitalized on the ward before surgery as part of routine clinical care and receive the routine hospital evening meal on the day before surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 65 years or older
  • Scheduled for elective noncardiac surgery
  • Scheduled to receive general anesthesia
  • I-III
  • Sufficient cognitive and communication ability to complete the Edmonton Frail Scale assessment
  • Written

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery
  • Active bleeding or hemodynamic instability
  • Vasopressor or inotropic support before induction
  • No oral intake on the evening before surgery (e.g., nasogastric decompression, ileus, full bowel preparation)
  • Permanent pacemaker or implanted device suppressing chronotropic response
  • Atrial fibrillation or other arrhythmias impairing the reliability of oscillometric blood pressure measurement
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Postprandial hypotension

    Patients aged 65 years and older scheduled for elective noncardiac surgery under general anesthesia who meet the criteria for postprandial hypotension (a decrease in systolic blood pressure of ≥20 mmHg from the pre-meal value, or a fall to ≤90 mmHg when the pre-meal value is ≥100 mmHg, within 120 minutes after the routine hospital evening meal on the day before surgery).

  • No postprandial hypotension

    Patients aged 65 years and older scheduled for elective noncardiac surgery under general anesthesia who do not meet the criteria for postprandial hypotension.

06

What researchers measure

Primary outcomes

  1. Incidence of post-induction hypotension

    Description: Proportion of patients with mean arterial pressure \<65 mmHg and/or a ≥30% decrease from the pre-induction baseline mean arterial pressure (mean of two measurements), measured non-invasively at 2-minute intervals from induction until 20 minutes after induction or surgical incision, whichever occurs first.

    Time frame: Up to 20 minutes after induction of anesthesia

Secondary outcomes

  1. Prevalence of postprandial hypotension

    Proportion of patients with a decrease in systolic blood pressure of ≥20 mmHg from the pre-meal value, or a fall to ≤90 mmHg when the pre-meal value is ≥100 mmHg.

    Time frame: Before and at 30, 60, 90 and 120 minutes after the evening meal on the day before surgery

  2. Change in systolic blood pressure after the meal

    Change in systolic blood pressure (mmHg) from the pre-meal value at 30, 60, 90 and 120 minutes after the meal.

    Time frame: Before and at 30, 60, 90 and 120 minutes after the evening meal on the day before surgery

  3. Change in diastolic blood pressure after the meal

    Change in diastolic blood pressure (mmHg) from the pre-meal value at 30, 60, 90 and 120 minutes after the meal.

    Time frame: Before and at 30, 60, 90 and 120 minutes after the evening meal on the day before surgery

  4. Change in mean arterial pressure after the meal

    Change in mean arterial pressure (mmHg) from the pre-meal value at 30, 60, 90 and 120 minutes after the meal.

    Time frame: Before and at 30, 60, 90 and 120 minutes after the evening meal on the day before surgery

  5. Change in heart rate after the meal

    Change in heart rate (beats/min) from the pre-meal value at 30, 60, 90 and 120 minutes after the meal.

    Time frame: Before and at 30, 60, 90 and 120 minutes after the evening meal on the day before surgery

  6. Maximum postprandial decrease in systolic blood pressure

    Maximum decrease in systolic blood pressure (mmHg) from the pre-meal value.

    Time frame: Before and at 30, 60, 90 and 120 minutes after the evening meal on the day before surgery

  7. Maximum percentage postprandial decrease in systolic blood pressure

    Maximum decrease in systolic blood pressure from the pre-meal value, expressed as a percentage of the pre-meal value (%).

    Time frame: Before and at 30, 60, 90 and 120 minutes after the evening meal on the day before surgery.

  8. Lowest mean arterial pressure after induction

    Lowest mean arterial pressure (mmHg) recorded after induction of anesthesia.

    Time frame: Up to 20 minutes after induction of anesthesia

  9. Maximum decrease in mean arterial pressure after induction

    Maximum decrease in mean arterial pressure (mmHg) from the pre-induction baseline value.

    Time frame: Up to 20 minutes after induction of anesthesia

  10. Maximum percentage decrease in mean arterial pressure after induction

    Maximum decrease in mean arterial pressure from the pre-induction baseline value, expressed as a percentage of the baseline value (%).

    Time frame: Up to 20 minutes after induction of anesthesia

  11. Change in systolic blood pressure after induction

    Change in systolic blood pressure (mmHg) from the pre-induction baseline value.

    Time frame: Up to 20 minutes after induction of anesthesia

  12. Change in diastolic blood pressure after induction

    Change in diastolic blood pressure (mmHg) from the pre-induction baseline value.

    Time frame: Up to 20 minutes after induction of anesthesia

  13. Change in heart rate after induction

    Change in heart rate (beats/min) from the pre-induction baseline value.

    Time frame: Up to 20 minutes after induction of anesthesia

  14. Duration of post-induction hypotension episode

    Time (minutes) from the onset of post-induction hypotension until mean arterial pressure returns to ≥65 mmHg and to \>70% of the pre-induction baseline value.

    Time frame: Up to 20 minutes after induction of anesthesia

  15. Vasopressor/inotrope use after induction

    Proportion of patients receiving at least one dose of a vasopressor or inotropic agent.

    Time frame: Up to 20 minutes after induction of anesthesia

  16. Need for additional vasopressor/inotrope treatment after induction

    Proportion of patients requiring a second bolus or an additional vasopressor or inotropic agent.

    Time frame: Up to 20 minutes after induction of anesthesia

  17. Cumulative ephedrine dose after induction

    Cumulative dose of ephedrine (mg) administered after induction of anesthesia.

    Time frame: Up to 20 minutes after induction of anesthesia

  18. Cumulative norepinephrine dose after induction

    Cumulative dose of norepinephrine (µg), including bolus and infusion doses, administered after induction of anesthesia.

    Time frame: Up to 20 minutes after induction of anesthesia

Other outcomes

  1. Postoperative intensive care unit admission

    Proportion of patients admitted to the intensive care unit after surgery

    Time frame: Day of surgery

  2. Length of intensive care unit stay

    Duration of intensive care unit stay (days).

    Time frame: Up to 30 days after surgery

  3. Length of hospital stay

    Duration of hospital stay after surgery (days).

    Time frame: Up to 30 days after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006 Sep;35(5):526-9. doi: 10.1093/ageing/afl041. Epub 2006 Jun 6. No abstract available. PubMed 16757522 ↗
  • Li T, Zang H, Che L, Cui Q, Xu L. Correlation between postprandial hypotension and post-induction hypotension in the elderly: a protocol for a prospective cohort study. BMJ Open. 2025 May 30;15(5):e095466. doi: 10.1136/bmjopen-2024-095466. PubMed 40447437 ↗
  • Lee HJ, Kim YJ, Woo JH, Oh HW. Preoperative Frailty Is an Independent Risk Factor for Postinduction Hypotension in Older Patients Undergoing Noncardiac Surgery: A Retrospective Cohort Study. J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1):glad229. doi: 10.1093/gerona/glad229. PubMed 37749851 ↗
  • Huang L, Li S, Xie X, Huang X, Xiao LD, Zou Y, Jiang W, Zhang F. Prevalence of postprandial hypotension in older adults: a systematic review and meta-analysis. Age Ageing. 2024 Feb 1;53(2):afae022. doi: 10.1093/ageing/afae022. PubMed 38411408 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared, as the informed consent obtained from participants does not include sharing of their data with other researchers, and to protect participant confidentiality.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for May 2027, 6 months after the start.

Of 289 non-industry observational studies under Frailty, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's planned 6 months is below that.

Counting every sponsor, half of 292 studies reached it within 29 months; a quarter within 12 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2026
First posted
Nov 4, 2026
StartActual
Nov 5, 2026
Primary completionEst.
May 5, 2027
CompletionEst.
Jun 5, 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 10, 2026
Sites
Konya City Hospital is now Recruiting
Nov 10, 2026
Start date
Nov 9, 2026→Nov 5, 2026 (actual)
Nov 10, 2026
Primary completion
May 9, 2027→May 5, 2027
Nov 10, 2026
Study completion
Jun 9, 2027→Jun 5, 2027
Nov 10, 2026
Registered
First appeared on the registry
Nov 4, 2026
Show all 2 updates
  1. Nov 10, 2026
    Not yet recruiting→Recruiting
    Konya City Hospital is now Recruiting
    Start date Nov 9, 2026→Nov 5, 2026 (now actual)
    Primary completion May 9, 2027→May 5, 2027
    Study completion Jun 9, 2027→Jun 5, 2027
    + 2 other changes: verification date and responsible party
  2. Nov 4, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07914920
Lead sponsor
Konya City Hospital
Responsible party
Asiye Özkan Kaya (Principal Investigator, Konya City Hospital) — Principal investigator
First posted
Nov 4, 2026
Start date
Nov 5, 2026
Primary completion
May 5, 2027 (estimated)
Completion
Jun 5, 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Asiye Özkan Kaya, MD
Contact
asiyenur_94@hotmail.com
+90 538 929 03 03
Esma Karaarslan, MD
Contact
esmaayvaz@gmail.com
+90 505 731 7061
Asiye Özkan Kaya
principal investigator · Konya City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion